A DOUBLE-BLIND CLINICAL-TRIAL OF FENTICONAZOLE (2-PERCENT) SPRAY VERSUS NAFTIFINE (1-PERCENT) SPRAY IN PATIENTS WITH CUTANEOUS MYCOSES

被引：6
作者：
LEISTE, D
BRAUN, W
FEGELER, W
FEGELER, K
STARY, A
RUPING, KW
KLASCHKA, F
COLLI, E
SARTANI, A
机构：
[1] KLINIKUM STEGLITZ, BERLIN, GERMANY
[2] RECORDATI SPA, DEPT MED, MILAN, ITALY
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 1989年 / 11卷 / 09期
关键词：
D O I：
10.1185/03007998909112673
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：567 / 575
页数：9
相关论文
共 15 条
[1]   CLINICAL-EVALUATION OF FENTICONAZOLE CREAM IN CUTANEOUS FUNGAL-INFECTIONS - A COMPARISON WITH MICONAZOLE CREAM [J].
ATHOWFROST, TAM ;
FREEMAN, K ;
MANN, TAN ;
MARKS, R ;
VOLLUM, D ;
WARIN, AP .
CURRENT MEDICAL RESEARCH AND OPINION, 1986, 10 (02) :107-116
[2]   INVITRO ANTI-MYCOTIC ACTIVITY OF FENTICONAZOLE (REC 15/1476) [J].
COSTA, AL .
MYKOSEN, 1982, 25 (01) :47-52
[3]  
FINZI A, 1986, MYCOSES, V29, P41
[4]   FENTICONAZOLE CREAM ONCE DAILY IN DERMATOMYCOSIS, A DOUBLE-BLIND CONTROLLED TRIAL VERSUS BIFONAZOLE [J].
JUNG, EG ;
BISCO, A ;
AZZOLLINI, E ;
SARTANI, A ;
RUFFMANN, R .
DERMATOLOGICA, 1988, 177 (02) :104-108
[5]  
KERRIDGE D, 1988, Drugs of Today, V24, P705
[6]  
KOKOSCHKA EM, 1986, MYCOSES, V29, P45
[7]  
NARDI D, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2123
[8]  
Ryder N S, 1988, Ann N Y Acad Sci, V544, P208, DOI 10.1111/j.1749-6632.1988.tb40405.x
[9]   EXPERIMENTAL APPROACHES TO ANTIFUNGAL CHEMOTHERAPY [J].
RYLEY, JF ;
WILSON, RG ;
GRAVESTOCK, MB ;
POYSER, JP .
ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY, 1981, 18 :49-176
[10]  
SARTANI A, 1988, CURR THER RES CLIN E, V43, P1194
12